Medipal Holdings <7459.T>-6mth group results

Oct 29 (Reuters) -

MEDIPAL HOLDINGS CORP

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

6 months ended 6 months ended Full year to Full year ended

Sep 30, 2010 Sep 30, 2009 Mar 31, 2011 Mar 31, 2010

LATEST YEAR-AGO COMPANY YEAR-AGO

H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 1.32 trln 1.27 trln 2.65 trln

(+3.8 pct) (+3.1 pct) (+4.2%)
Operating 15.69 9.25 31.20

(+69.6 pct) (-13.5 pct) (+69.3%)
Recurring 19.69 13.55 39.40

(+45.3 pct) (-26.8 pct) (+47.0%)
Net 4.71 3.12 14.70

(+51.3 pct) (-70.3 pct) (+650.8%)
EPS Y20.10 Y13.15 Y62.67
Annual div Y18.00 Y18.00
-Q2 div Y9.00 Y9.00
-Q4 div Y9.00 Y9.00

NOTE - Medipal Holdings Corp is a major pharmaceutical wholesaler.

For latest earnings estimates made by Toyo Keizai, please
double click on 7459.TK1.